Desprescripción de tratamientos de larga duración con bisfosfonatos para la osteoporosis en atención primaria en el País Vasco

Etxeberria, Arritxu; Iribar, Josune; Hernando, Javier; Idarreta, Ignacia; Vergara, Itziar; Mozo, Carmela; Vrotsou, Kalliopi; Belzunegui, Joaquín; Lekuona, Arantxa.
Gac. sanit. (Barc., Ed. impr.) ; 31(1): 35-39, ene.-feb. 2017. graf, tab
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-159665

Documentos relacionados

  1. [Deprescribing long-term treatments with bisphosphonates for osteoporosis in primary care in the Basque Country (Spain)].
  2. Empowering the Medicinal Applications of Bisphosphonates by Unveiling their Synthesis Details.
  3. Recommendations on deprescribing of bisphosphonates in osteoporosis guidelines: a systematic review.
  4. Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise.
  5. Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice.
  6. Gaps in evidence on treatment of male osteoporosis: a Research Agenda.
  7. Health-related quality of life of men with primary osteoporosis and its changes after bisphosphonates treatment.
  8. Intravenous neridronate is effective in regional migratory osteoporosis.
  9. Efficacy of osteoporosis pharmacological treatments in men: a systematic review and meta-analysis.
  10. Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis.